Honorary Professor Vicki Whitehall
Honorary Professor

Vicki Whitehall

Email: 

Availability

Honorary Professor Vicki Whitehall is:
Available for supervision

Qualifications

  • Bachelor of Science, The University of Queensland
  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Vicki Whitehall’s works on UQ eSpace

117 works between 1999 and 2026
All (117) Journal Article (77) Other Outputs (1) Conference Publication (39)

1 - 20 of 117 works

2026

Journal Article

Unraveling lncRNA diversity at a single cell resolution and in a spatial context across different cancer types

Prakrithi, P., Vo, Tuan, Xiong, Zherui, Vu, Hani, Nguyen, Loan T., Newman, Andrew, Wilhelmey, Julie, Whitehall, Vicki, Cruz, Jazmina L. Gonzalez, Wood, Simon, Mallett, Andrew J., Gupta, Ishaan and Nguyen, Quan (2026). Unraveling lncRNA diversity at a single cell resolution and in a spatial context across different cancer types. Nature Methods, 23 (6), 1236-1249. doi: 10.1038/s41592-026-03071-4

Unraveling lncRNA diversity at a single cell resolution and in a spatial context across different cancer types

2026

Journal Article

Attenuation of the CpG island methylator phenotype and lack of WNT signalling activation restrains Kras mutant intestinal neoplasia

Fennell, Lochlan, Liu, Cheng, Kane, Alexandra, Tria, Simon, Borowsky, Jennifer, Chai, Lu, Randall-Demllo, Sarron, McKeone, Diane, Bond, Catherine, Leggett, Barbara and Whitehall, Vicki (2026). Attenuation of the CpG island methylator phenotype and lack of WNT signalling activation restrains Kras mutant intestinal neoplasia. British Journal of Cancer, 134 (8), 1230-1239. doi: 10.1038/s41416-025-03271-3

Attenuation of the CpG island methylator phenotype and lack of WNT signalling activation restrains Kras mutant intestinal neoplasia

2025

Journal Article

Developing new immunotherapy approaches for colorectal cancer

Kelly, Gregory, Nowlan, Bianca, Tria, Simon Manuel, Nikkhoo, Afshin, Bond, Catherine and Whitehall, Vicki (2025). Developing new immunotherapy approaches for colorectal cancer. Cancers, 17 (24) 3929, 1-25. doi: 10.3390/cancers17243929

Developing new immunotherapy approaches for colorectal cancer

2025

Journal Article

Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis

Alam, Zakia, Nightingale, Rebecca, Lesmana, Analia, Liu, Cheng, Jenkins, Laura J., Richardson, Mark F., Croft, Lawrence, Luk, Ian Y., Reehorst, Camilla M., Chionh, Fiona, Vukelic, Natalia, Basheer, Faiza, Tulchinsky, Eugene, Badshah, Joshua, Dumenil, Troy, Bakiri, Latifa, Wagner, Erwin F., Tebbutt, Niall C., Whitehall, Vicki, Mariadason, John M. and Dhillon, Amardeep S. (2025). Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis. iScience, 28 (11) 113875, 1-9+. doi: 10.1016/j.isci.2025.113875

Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis

2025

Journal Article

Dietary pattern and lifestyle risk factors for sessile serrated precursors to colorectal cancer

Van Der Pols, Jolieke C., Johnston, Elizabeth A., Whitehall, Vicki L. J., Ibiebele, Torukiri I., Hewett, David G. and Leggett, Barbara A. (2025). Dietary pattern and lifestyle risk factors for sessile serrated precursors to colorectal cancer. British Journal of Nutrition, 134 (1), 35-46. doi: 10.1017/S0007114525103747

Dietary pattern and lifestyle risk factors for sessile serrated precursors to colorectal cancer

2025

Journal Article

Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes

Hazelwood, Emma, Canson, Daffodil M., Deslandes, Benedita, Wang, Xuemin, Kho, Pik Fang, Legge, Danny, Constantinescu, Andrei-Emil, Lee, Matthew A., Bishop, D. Timothy, Chan, Andrew T., Gruber, Stephen B., Hampe, Jochen, Le Marchand, Loic, Woods, Michael O., Pai, Rish K., Schmit, Stephanie L., Figueiredo, Jane C., Zheng, Wei, Huyghe, Jeroen R., Murphy, Neil, Gunter, Marc J., Richardson, Tom G., Whitehall, Vicki L. J., Vincent, Emma E., Glubb, Dylan M. and O’Mara, Tracy A. (2025). Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes. Nature Communications, 16 (1) 5043, 1-13. doi: 10.1038/s41467-025-60275-6

Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes

2023

Conference Publication

KRAS mutant bowel cancers segregate into two distinct subgroups

Borowsky, J., Su, C., Fennell, L., Burge, M., Liu, J., Costa, A. Dias, Ogino, S., Mckeone, D., Olsen, K., Badshah, J., Bond, C., Nowlan, B., Tria, S., Laki, V., Walker, N., Brown, I., Bettington, M., Leggett, B. and Whitehall, V. (2023). KRAS mutant bowel cancers segregate into two distinct subgroups. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Hoboken, NJ United States: Wiley.

KRAS mutant bowel cancers segregate into two distinct subgroups

2023

Conference Publication

Determining if osteopontin is an immune checkpoint of KRAS mutant colorectal cancer

Nowlan, B., Borowsky, J., Dumenil, T., Tria, S., Wright, J., Fennell, L., Bond, C., McKeone, D., Hartel, G., Woods, S., Leggett, B. and Whitehall, V. (2023). Determining if osteopontin is an immune checkpoint of KRAS mutant colorectal cancer. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Richmond, VIC Australia: John Wiley & Sons.

Determining if osteopontin is an immune checkpoint of KRAS mutant colorectal cancer

2023

Journal Article

Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer

Ramsay, Robert G., Whitehall, Vicki and Flood, Michael P. (2023). Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer. Growth Factors, 41 (4), 179-191. doi: 10.1080/08977194.2023.2227274

Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer

2023

Journal Article

The therapeutic landscape for KRAS-Mutated colorectal cancers

Tria, Simon Manuel, Burge, Matthew E. and Whitehall, Vicki L. J. (2023). The therapeutic landscape for KRAS-Mutated colorectal cancers. Cancers, 15 (8) 2375, 1-25. doi: 10.3390/cancers15082375

The therapeutic landscape for KRAS-Mutated colorectal cancers

2023

Journal Article

The efficacy of using patient-derived organoids to predict treatment response in colorectal cancer

Su, Chang, Olsen, Kelly A., Bond, Catherine E. and Whitehall, Vicki L. J. (2023). The efficacy of using patient-derived organoids to predict treatment response in colorectal cancer. Cancers, 15 (3) 805, 1-16. doi: 10.3390/cancers15030805

The efficacy of using patient-derived organoids to predict treatment response in colorectal cancer

2022

Conference Publication

Proof of principle that loss of mismatch repair protein reduces tumor burden in mouse model of gastric cancer

Huber, Anne, Dijkstra, Christine, Whitehall, Vicki, Ernst, Matthias and Eissmann, Moritz (2022). Proof of principle that loss of mismatch repair protein reduces tumor burden in mouse model of gastric cancer. AACR Special Conference: Tumor Immunology and Immunotherapy, Boston, MA United States, 21-24 October 2022. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/2326-6074.tumimm22-a49

Proof of principle that loss of mismatch repair protein reduces tumor burden in mouse model of gastric cancer

2022

Journal Article

Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis

Fennell, Lochlan J., Hartel, Gunter, McKeone, Diane M., Bond, Catherine E., Kane, Alexandra, Leggett, Barbara A., Patch, Ann-Marie and Whitehall, Vicki L.J. (2022). Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis. Cell Reports Methods, 2 (11) 100323, 1-14. doi: 10.1016/j.crmeth.2022.100323

Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis

2022

Journal Article

Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

Luk, Ian Y., Jenkins, Laura J., Schoffer, Kael L., Ng, Irvin, Tse, Janson W. T., Mouradov, Dmitri, Kaczmarczyk, Stanislaw, Nightingale, Rebecca, Burrows, Allan D., Anderson, Robin L., Arango, Diego, Dopeso, Higinio, Croft, Larry, Richardson, Mark F., Sieber, Oliver M., Liao, Yang, Mooi, Jennifer K., Vukelic, Natalia, Reehorst, Camilla M., Afshar-Sterle, Shoukat, Whitehall, Vicki L. J., Fennell, Lochlan, Abud, Helen E., Tebbutt, Niall C., Phillips, Wayne A., Williams, David S., Shi, Wei, Mielke, Lisa A., Ernst, Matthias ... Mariadason, John M. (2022). Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. Cell Death and Differentiation, 29 (11), 2288-2302. doi: 10.1038/s41418-022-01016-w

Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

2021

Journal Article

Global methylome scores correlate with histological subtypes of colorectal carcinoma and show different associations with common clinical and molecular features

Turpín‐sevilla, María Del Carmen, Pérez‐sanz, Fernando, García‐solano, José, Sebastián‐león, Patricia, Trujillo‐santos, Javier, Carbonell, Pablo, Estrada, Eduardo, Tuomisto, Anne, Herruzo, Irene, Fennell, Lochlan J., Mäkinen, Markus J., Rodríguez‐braun, Edith, Whitehall, Vicki L. J., Conesa, Ana and Conesa‐zamora, Pablo (2021). Global methylome scores correlate with histological subtypes of colorectal carcinoma and show different associations with common clinical and molecular features. Cancers, 13 (20) 5165, 5165. doi: 10.3390/cancers13205165

Global methylome scores correlate with histological subtypes of colorectal carcinoma and show different associations with common clinical and molecular features

2021

Conference Publication

Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer

Su, C., Bond, C., Fennell, L., Kerr, G., Jarde, T., Micati, D., Engel, R., Chan, W. H., Hlavca, S., Archer, S., Mcmurrick, P., Hammerlindl, H., Lim, F., Salik, B., Mckeone, D., Hartel, G., Leggett, B., Schaider, H., Abud, H., Boyle, G., Burge, M. and Whitehall, V. (2021). Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer. GESA AGW 2021, Online, 4 - 12 September 2021. HOBOKEN: WILEY.

Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer

2021

Journal Article

Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium

Fennell, Lochlan, Kane, Alexandra, Liu, Cheng, McKeone, Diane, Hartel, Gunter, Su, Chang, Bond, Catherine, Bettington, Mark, Leggett, Barbara and Whitehall, Vicki (2021). Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium. Gut, 71 (6) 322166, 1127-1140. doi: 10.1136/gutjnl-2020-322166

Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium

2021

Journal Article

Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment

Borowsky, Jennifer, Haruki, Koichiro, Lau, Mai Chan, Costa, Andressa Dias, Vayrynen, Juha P., Ugai, Tomotaka, Arima, Kota, Da Silva, Annacarolina, Felt, Kristen D., Zhao, Melissa, Gurjao, Carino, Twombly, Tyler S., Fujiyoshi, Kenji, Vayrynen, Sara A., Hamada, Tsuyoshi, Mima, Kosuke, Bullman, Susan, Harrison, Tabitha A., Phipps, Amanda I., Peters, Ulrike, Ng, Kimmie, Meyerhardt, Jeffrey A., Song, Mingyang, Giovannucci, Edward L., Wu, Kana, Zhang, Xuehong, Freeman, Gordon J., Huttenhower, Curtis, Garrett, Wendy S. ... Ogino, Shuji (2021). Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment. Clinical Cancer Research, 27 (10), 2816-2826. doi: 10.1158/1078-0432.CCR-20-4009

Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment

2021

Journal Article

Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia

Kane, Alexandra M., Liu, Cheng, Fennell, Lochlan J., McKeone, Diane M., Bond, Catherine E., Pollock, Pamela M., Young, Graeme, Leggett, Barbara A. and Whitehall, Vicki L. J. (2021). Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia. British Journal of Cancer, 124 (11), 1820-1827. doi: 10.1038/s41416-021-01339-4

Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia

2021

Journal Article

Curcumin chemoprevention reduces the incidence of Braf mutant colorectal cancer in a preclinical study

Kane, Alexandra M., Liu, Cheng, Akhter, Dewan T., McKeone, Diane M., Bell, Craig A., Thurecht, Kristofer J., Leggett, Barbara A. and Whitehall, Vicki L. J. (2021). Curcumin chemoprevention reduces the incidence of Braf mutant colorectal cancer in a preclinical study. Digestive Diseases and Sciences, 66 (12), 4326-4332. doi: 10.1007/s10620-020-06752-y

Curcumin chemoprevention reduces the incidence of Braf mutant colorectal cancer in a preclinical study

Availability

Honorary Professor Vicki Whitehall is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Personalised Medicine for Colorectal Cancer

    Principal Advisor

    Other advisors: Professor David Clark

  • Doctor Philosophy

    Improving Immunotherapy Efficacy for Colorectal Cancer

    Principal Advisor

    Other advisors: Professor David Clark

  • Doctor Philosophy

    Discovering Novel Immunotherapeutic Targets for Colorectal Cancer

    Principal Advisor

Completed supervision

Enquiries

For media enquiries about Honorary Professor Vicki Whitehall's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au